bscruggs

Genesis Mining back to normal?!?!

I am starting to get payouts from Genesis Mining again. It looks like their issues may be resolved now. https://www.youtube.com/watch?v=gGFHz1evM...

Mysterium continues to rise

The price of Mysterium has increased to $1.50 with a 50% increase in the last 24 hours. The rank on coinmarketcap.com is 87. I was introduced to Mysterium by Da...

Mysterium breaking out

Mysterium (MYST) is up more than 35% in the last 24 hours. Mysterium foundation is developing Mysterium Network – an Open source software, powering a Decentrali...

Insect of the day

Found this amazing creature on my back porch. Looks just like a leaf until you take a closer look!...

Did someone say fetch?

Pick a toy, any toy!...

LIVE: $300 FREE STEEM GIVEAWAY!

If you're reading this, it's not too late! I am currently live on YouTube giving away FREE STEEM! About $300 dollars worth! This time its for hitting 13,000 sub...

Soaking up the sun

Catching some rays in the backyard. One happy vizsla....

An evening stroll with the deer

We went for a walk a dusk to avoid today's heat as much as possible. Great to get out of the house after spending much of the day inside. We were greeted by a f...

Alt-News #4: Storj integrate with FileZilla / IOTA & F6S team up and list of IOTA business connections / Enterprise Ethereum Alliance becomes bigger

The Blockchain cloudstorage project Storj has created a graphical user interface for storing files easier on the Storj network. They have built a C library call...

Peaceful yard and sunset

Enjoying the evening sitting on the back porch listening to the crickets and frogs....

Sunset

...

Baltimore Orioles

Oriole Park at Camden Yards!...

Spark Therapeutics interim data

Spark Therapeutics (NASDAQ: ONCE) was up 9.21% in trading on Wednesday, July 5, 2017, closing at $65.56. $65 has been a resistance point in recent months. The c...

Who will Gilead acquire?

The buzz around a potential acquisition by Gilead continues. Last week a new name entered the ring - Vertex Pharmaceuticals. Leerink's Geoffrey Porges suggested...